financetom
Business
financetom
/
Business
/
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
Sep 15, 2025 4:11 AM

ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. ( AVNS ) , a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.

Nexus is the maker of the proprietary TKO® anti-reflux needleless connector technology, designed to support safer, more consistent nutrition and medication delivery in high-acuity settings, including Neonatal and Pediatric Intensive Care Units (NICUs and PICUs).

The acquisition adds complementary technology to Avanos' Specialty Nutrition Systems business and reinforces the company's focus on safe, reliable therapy delivery for the neonatal patient population.

"This acquisition is a clear extension of our strategy to deliver smarter, safer solutions across the critical care spectrum," said Dave Pacitti, Avanos chief executive officer. "We are proud to add the Nexus TKO® technology and the full breadth of Nexus' offerings to our portfolio as we continue investing in meaningful innovation that helps clinicians provide consistent care and improve outcomes for patients who need it most."

The TKO® needleless connector features a patented, pressure-activated tri-seal silicone valve that minimizes blood reflux – a known contributor to catheter occlusions, therapy delays, and infection risk during IV-based nutrition and medication delivery.*

"Nexus TKO® fits naturally into our Specialty Nutrition Systems business and is expected to deliver immediate value in NICU and PICU care," said Kerr Holbrook, Avanos' chief commercial officer. "It's a practical, trusted solution that helps clinicians reduce disruptions and deliver therapy with greater consistency and ease."

Avanos financed the acquisition with available cash. The company expects the acquisition to be immediately accretive to both revenue growth and earnings per share.

About Avanos Medical ( AVNS )

Avanos Medical ( AVNS ) is a medical technology company focused on delivering clinically superior medical device solutions that help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical ( AVNS ) on X (@AvanosMedical), LinkedIn and Facebook.

About Nexus Medical

Founded in 2001, Nexus Medical invented the anti-reflux category in needleless connectors to solve the unintended consequences of blood reflux in IV catheters, including intraluminal thrombotic occlusions, catheter failure, and infections. As the most studied needleless connector on the market, the Nexus TKO® anti-reflux technology is an evidence-based way to simplify the complexity of IV therapy and improve patient safety. For more information, call (913) 451-2234 or visit www.nexusmedical.com.

*CLAIM ON FILE

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-acquires-nexus-medical-to-strengthen-nutrition-and-medication-delivery-in-critical-care-302555789.html

SOURCE Avanos Medical ( AVNS )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lockheed has moon lander plans that could meet NASA's need for SpaceX alternative, company VP says
Lockheed has moon lander plans that could meet NASA's need for SpaceX alternative, company VP says
Oct 20, 2025
WASHINGTON, Oct 20 (Reuters) - Lockheed Martin ( LMT ) this year has been performing significant technical and programmatic analysis for astronaut lunar landers that could fulfill NASA's need for an alternative to SpaceX's Starship lander under the flagship U.S. moon program, a Lockheed vice president told Reuters in a statement on Monday. ...
ACCO GROUP HOLDINGS LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
ACCO GROUP HOLDINGS LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING
Oct 20, 2025
Hong Kong, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ACCO GROUP HOLDINGS LIMITED ( ACCL ) , a corporate services provider headquartered in Hong Kong, today announced the closing of its initial public offering (the “Offering”) of 1,400,000 ordinary shares (the “Ordinary Shares”) at the price of $4.00 per share (the “Offering Price”). The Ordinary Shares commenced trading on the Nasdaq...
The Crypto Company Completes Majority Acquisition of Starchive.io, Inc.
The Crypto Company Completes Majority Acquisition of Starchive.io, Inc.
Oct 20, 2025
Bringing Cultural Assets to the Blockchain Era MALIBU, CA / ACCESS Newswire ( ACCS ) / October 20, 2025 / The Crypto Company ( CRCW ) (TCC) today announced the completion of its previously disclosed acquisition of a majority interest in Starchive, a leading content management and monetization platform that safeguards and powers more than $1 Billion in cultural assets....
KittyHawk Acquires Exit Ventures; Paul Burgon Joins as Partner to Lead Energy & Climate Investments
KittyHawk Acquires Exit Ventures; Paul Burgon Joins as Partner to Lead Energy & Climate Investments
Oct 20, 2025
LOS ANGELES, Oct. 20, 2025 /PRNewswire/ -- KittyHawk, a technology investment firm dedicated to supporting innovative seed to late-stage pre-IPO companies, today announced the acquisition of Exit Ventures, an early-stage venture firm focused on renewable energy, AI infrastructure, and sustainable materials. As part of the transaction, Exit Ventures' founder Paul Burgon will join KittyHawk as a Partner, bringing more than...
Copyright 2023-2026 - www.financetom.com All Rights Reserved